We are experts in the field of bioengineering and entered the world market in 2016, presenting to the world 4 new varieties of medical marijuana, which entered the ranking of the best varieties in the world. Since 2017, our company has funded and facilitated the launch of a new network of medical marijuana retail stores in the US state of California. Over the past year, the capitalization of our company has grown 2 times breaking the mark of $70 000 000. In order to maintain its position in the world market, we have launched production for the processing of cannabis into medicines and attracted investments of $50 000 000, at the moment our products are supplied in bulk to 5 countries of the Northern hemisphere Venezuela, Guyana, Colombia, Suriname,French Guiana. At the end of 2018, our team of analysts decided to accept investments from private investors in order to increase the company's capital turnover and get more profit. At the moment we accept investments from individuals over the age of 21.